Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
98,685,316
-
Number of holders
-
164
-
Total 13F shares, excl. options
-
121,628,630
-
Shares change
-
-14,368,664
-
Total reported value, excl. options
-
$536,393,039
-
Value change
-
-$65,698,797
-
Put/Call ratio
-
44%
-
Number of buys
-
98
-
Number of sells
-
-60
-
Price
-
$4.41
Significant Holders of GoodRx Holdings, Inc. - Common Stock (GDRX) as of Q1 2025
204 filings reported holding GDRX - GoodRx Holdings, Inc. - Common Stock as of Q1 2025.
GoodRx Holdings, Inc. - Common Stock (GDRX) has 164 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 121,628,630 shares
.
Largest 10 shareholders include Francisco Partners Management, LP (60,078,184 shares), VANGUARD GROUP INC (8,624,872 shares), LAKEWOOD CAPITAL MANAGEMENT, LP (4,885,747 shares), AMERIPRISE FINANCIAL INC (4,634,771 shares), Silver Lake Group, L.L.C. (3,532,276 shares), Petrus Trust Company, LTA (3,167,015 shares), RENAISSANCE TECHNOLOGIES LLC (3,011,038 shares), DIMENSIONAL FUND ADVISORS LP (2,293,710 shares), Rip Road Capital Partners LP (1,923,068 shares), and 8 KNOTS MANAGEMENT, LLC (1,838,011 shares).
This table shows the top 164 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.